Mavengity Expands into B2B Research
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the Article8th Circuit ruling
7 storiesHill meeting with three committee chairs (Huang agreed) Dec 1
7 storiesS-1 public filing
1 storySenate committee report Nov 20
1 storyCourt resolves the dismissal and stay motions Nov 20
1 storyComment deadline on the RFI Nov 23
The SEC obtained emergency relief against Indianapolis-based Backward Hat Capital, alleging a $560 million offering fraud that raised money from more than 2,000 investors.
The FDIC proposed implementing the ROAD to Housing Act's custodial deposit provision, letting eligible small banks exclude up to 20 percent of qualifying custodial deposits from brokered deposit treatment.
A federal judge denied The New York Times' motion to dismiss Trump's $15 billion defamation suit, allowing seven of 34 challenged statements to proceed toward a possible trial.
The n0n group posted contact data for about 16,000 JPMorgan Chase customers and smaller sets from Visa and Mastercard after a ransom deadline expired. No payment data was exposed.
Anthropic opened its Nasdaq debut at a $2 trillion valuation after the largest IPO ever, then closed up 17 percent as the first-day surge faded.
California Attorney General Rob Bonta served Nvidia with an investigative subpoena over whether the company or former CEO Jensen Huang let advanced chips or information reach China.
NYDFS settled with Rocket Mortgage and Mr. Cooper for $6.75 million over missed incident reports, MFA failures, and gaps in cybersecurity risk assessments.
Denmark's patient compensation system paid 31 people who developed a rare optic nerve condition after taking Wegovy or Ozempic, but the awards do not establish that the drugs caused it.
Sanofi is studying an acquisition of Insmed, the rare-disease drugmaker with a market value of about $26 billion, according to Bloomberg. Neither company confirmed a deal.
Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.
One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.
Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.
Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.
Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.
Forrester's Q3 2026 Wave scores ten providers against twenty nine criteria, cutting the field's criteria count for the first time, while a vendor that owns its content finishes last equal.
Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.
Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.
Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.
Owner Marko Pargo Ivanov is now writing the B2B Research desk directly, turning Forrester and Gartner category reports into plain-English breakdowns for buyers.
Read the ArticleWith James now writing full time for our Healthcare & Medical desk, Mavengity has formally expanded into dedicated medical authorship.
Read the Article